Clinical Trial Update: Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma [NA]

View source ↗

Summary

This clinical trial update reports on using etoposide, filgrastim, and plerixafor to improve stem cell mobilization in treating various non-Hodgkin lymphomas, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Etoposide (Etoposide)
• Filgrastim (filgrastim)
• Plerixafor (Plerixafor)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Grade III Lymphomatoid Granulomatosis | NA | Status: TERMINATED | Results posted: 2019-06-14